Uroplasty Announces Issuance of New Apparatus Patent for the Urgent PC Neuromodulation System Stimulator
Uroplasty, Inc. (NASDAQ: UPI) today announced the issuance of United States Patent No. 8,046,082 covering the stimulator used in the Urgent® PC Neuromodulation System. The Urgent PC Neuromodulation System is an office-based, non-surgical system, used to treat overactive bladder syndrome and the associated symptoms of urinary urge incontinence, urinary urgency and urinary frequency.
The new patent covers the reusable Urgent® PC stimulator. When connected to a thin needle electrode near the ankle to access the tibial nerve, the stimulator delivers current to the sacral nerve plexus that controls bladder and pelvic floor function.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.